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oecreasing  antibiotic  days,  mortality,  and  sepsis-related
ortality are  critical  goals  for  our  patients  in  the  neona-
al intensive  care  unit  (NICU).  In  a  prospective  design,  this
mall study  in  a  single  NICU  evaluated  the  implementation
f diagnostic  criteria  for  early-onset  sepsis  (EOS)  and  late-
nset sepsis  (LOS),  focused  on  stopping  antibiotics  early  if
ematologic and  CRP  tests  were  within  the  normal  range  for
eonates.
The study  by  Pinto  et  al.1 targeted  stopping  antibi-
tics after  48  hours  versus  treating  for  a  full  course  in
ulture-negative ‘‘possible  infections’’.  This  is  important,
s ‘‘possible  infections’’  likely  drives  antibiotic  usage  and
ays. This  study  reduced  EOS  antibiotic  days  primarily  by
eﬁning fewer  EOS  evaluations  as  ‘‘possible  infections’’,
hich roughly  translated  into  receiving  two  days  instead  of
even days  of  antibiotics  in  the  ﬁrst  week  after  birth.
LOS  antibiotic  days  and  diagnosis  of  LOS  were  not
ffected. This  remains  a  challenging  area.  These  ﬁndings  are
imilar to  studies  of  CLABSI  bundles,  which  while  demon-
trating lower  CLABSI  rates,  have  not  lowered  antibiotic
sage.2 This  may  be  partially  explained  in  that  most  studies
xamining antibiotics  and  sepsis  in  the  NICU  do  not  include
nformation on  the  deﬁnition  of  sepsis  used  and  data  on
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ttp://dx.doi.org/10.1016/j.jped.2013.06.001ther  infections  that  contribute  to  antibiotic  usage.  These
nclude, in  part,  urinary  tract  infections  (UTIs),  ventila-
or associated  pneumonia  (VAP),  necrotizing  enterocolitis
NEC), and  focal  bowel  perforation.  While  we  still  strug-
le with  diagnostic  criteria  for  VAP  in  neonates  in  the  NICU,
specially in  those  with  chronic  lung  disease,  the  diagnosis
f UTI,  NEC,  and  focal  bowel  perforation  are  more  clearly
eﬁned. Additionally,  improvements  to  diagnosing  viral
nfections are  needed  in  the  NICU.  If  we  are  able  to  make  a
iagnosis of  a  viral  infection,  antibiotics  would  more  readily
e discontinued  and  at  times  replaced  with  an  antiviral.
Obtaining  a  urine  culture  during  LOS  evaluation  is  still  not
tandard practice,  despite  studies  reporting  an  incidence  of
pproximately 8%  in  infants  <  1,500  grams.3--5 Studies  often
laim that  blood  cultures  are  not  sensitive  enough;  however,
he infection  may  not  be  in  the  bloodstream.  LOS  evaluations
hould include  a  urine  culture,  but  there  is  still  variation  in
ractice in  this  area.
Prevention of  infections  remains  a key  to  reducing  antibi-
tic days  after  the  ﬁrst  week  of  life.  In  the  area  of  fungal
nfections, antifungal  prophylaxis  has  been  shown  to  signif-
cantly reduce  the  number  of  antifungal  days  for  empiric,
resumed, and  culture-positive  Candida  infections.6
While  mortality  appeared  to  initially  decrease,  logis-
ic regression  did  not  ﬁnd  signiﬁcance  between  groups  for
oth total  and  sepsis-related  mortality.  Other  studies  have
eported an  association  with  an  increased  risk  for  mortality
hen third  generation  cephalosporins  are  frequently  used
or EOS.7 Speciﬁcally  with  treatment  of  culture-negative
arly-onset sepsis,  the  risk  for  NEC  is  increased.8
In  the  article’s  discussion,  early  diagnosis  and  antibiotic
se was  hypothesized  as  a  way  to  lower  neonatal  mortality
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with  sepsis.  This  has  been  demonstrated  in  a  recent  study
using an  electronic  monitoring  system,  since  an  early  detec-
tion system  of  LOS  (12-24  hours  prior  to  clinical  symptoms)
found a  signiﬁcantly  lower  overall  and  sepsis-associated
(within 30  days  of  infection)  mortality.9
Limitations  of  the  study  include  reasons  for  selection  of
the different  antibiotic  regimens  and  the  lack  of  a  speciﬁc
deﬁnition for  sepsis-related  mortality.
From  this  study,  other  NICUs  can  examine  whether  they
have similar  practices  already  in  place  or  if  this  is  an  area  for
quality improvement.  It  is  likely  that  the  post  intervention
rate for  possible  EOS  of  44%  can  be  further  lowered.  It  would
be insightful  for  larger  studies  and/or  data  sets  to  explore
some of  the  same  questions  in  this  article.  As  this  group  and
others continue  to  study  antibiotic  usage  patterns,  it  will
be critical  to  link  treatment  changes  with  important  clinical
outcomes in  prospective  studies.  If  we  are  able  to  do  so,  we
will be  able  to  provide  additional  evidence  for  future  best
practices.
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